ΒΗΜΑ Science, the science news source from Greek Sunday newspaper BHMA, on September 7, 2014, posted an extended and informative interview of Amyndas pharmaceuticals founder, Dr. John Lambris. In this article, which aimed at communicating the results of Dr. John Lambris’ scientific research to the public, Amyndas’ promising new drugs and their potential therapeutic applications are presented for the first time in a widely-read national Greek newspaper, conveying the profound impact that these new therapies can have for patients and health care systems internationally. The article created significant interest, with its wide readers’ audience commending and responding enthusiastically, hoping that these new therapies to be brought to patients soon.
To read article (in Greek): www.tovima.gr